Extensively drug-resistant Mycobacterium tuberculosis during a trend of decreasing drug resistance from 2000 through 2006 at a Medical Center in Taiwan

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Chih-Cheng LaiPo-Ren Hsueh

Abstract

Drug resistance rates are one of the most important aspects in the national tuberculosis (TB) control program, and drug-resistant TB, especially extensively drug-resistant (XDR) TB, is not well understood in Taiwan. The objectives of this study were to investigate the prevalence of drug resistance from 2000 through 2006 and to identify XDR TB isolates to elucidate the clinical characteristics of patients with XDR TB at National Taiwan University Hospital. The prevalence of drug resistance among clinical, nonduplicate Mycobacterium tuberculosis isolates was analyzed. Testing of susceptibility to antituberculosis agents, including isoniazid, rifampicin, ethambutol, streptomycin, rifabutin, ofloxacin, ethinamide, and para-aminosalicylic acid, was performed using the proportional method. Minimum inhibitory concentrations of amikacin, capreomycin, isepamycin, linezolid, cycloserine, ciprofloxacin, levofloxacin, moxifloxacin, and gemifloxacin were determined for 40 available multidrug-resistant M. tuberculosis isolates. Significant decreasing trends in rates of resistance to isoniazid, ethambutol, and at least 1 of the 3 first-line agents were observed among 2625 M. tuberculosis isolates from 2000 through 2006. Among these 2625 isola...Continue Reading

References

Jan 1, 1995·Drugs·M R Jacobs
Mar 1, 1997·Antimicrobial Agents and Chemotherapy·N LounisJ Grosset
Feb 15, 2001·American Journal of Infection Control·P D Wang, R S Lin
Sep 10, 2002·The Journal of Infection·P D Wang
Jun 27, 2003·Rheumatology·J Y WangK T Luh
Jul 3, 2003·The Lancet Infectious Diseases·Amy Sarah GinsburgWilliam R Bishai
Nov 14, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Amy Sarah GinsburgTimothy R Sterling
Oct 12, 2005·The Journal of Infection·Po-Ren HsuehKwen-Tay Luh
Dec 19, 2006·Lancet·Mohamed Abdel AzizUNKNOWN WHO/International Union Against Tuberculosis And Lung Disease Global Project on Anti-tuberculosis Drug Resistance Surveillan
Oct 31, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Hye-Ryoun KimJae-Joon Yim
Jan 4, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Christie Y JeonLaura E Via
Apr 29, 2008·Emerging Infectious Diseases·Ming-Chih YuRuwen Jou
Aug 7, 2010·Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi·Chia-Chuan YuChang-Hua Chen

❮ Previous
Next ❯

Citations

Feb 2, 2010·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·C C LaiP R Hsueh
Jul 24, 2010·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·W-L LiuP-R Hsueh
Oct 16, 2010·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·H-L HsuP-R Hsueh
Jan 18, 2011·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·C-C LaiP-R Hsueh
Aug 7, 2010·Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi·Chia-Chuan YuChang-Hua Chen
Nov 24, 2012·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Jung-Yien ChienPo-Ren Hsueh
Jul 30, 2011·The Journal of Antimicrobial Chemotherapy·Chih-Cheng LaiPo-Ren Hsueh
Sep 6, 2011·Emerging Infectious Diseases·Chih-Cheng LaiPo-Ren Hsueh
Oct 31, 2013·Clinical Rheumatology·Yu-Sheng ChangChung-Tei Chou
Dec 18, 2013·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·J-Y ChienP-R Hsueh
Feb 15, 2011·Journal of the Formosan Medical Association = Taiwan Yi Zhi·Shio-Shin Jean, Po-Ren Hsueh
Jun 19, 2012·Diagnostic Microbiology and Infectious Disease·Meng-Rui LeeKwen-Tay Luh
Mar 6, 2016·American Journal of Infection Control·Jingya ZhangLanlan Wang
Jul 8, 2011·Liver International : Official Journal of the International Association for the Study of the Liver·Isabelle Chemin, Christian Trépo
May 28, 2016·The Journal of Antimicrobial Chemotherapy·Samiksha GhimireJan-Willem C Alffenaar
Sep 21, 2010·Diagnostic Microbiology and Infectious Disease·Chih-Cheng LaiPo-Ren Hsueh
Jan 21, 2016·Antimicrobial Agents and Chemotherapy·Jung-Yien ChienPo-Ren Hsueh
May 25, 2016·Antimicrobial Agents and Chemotherapy·Jung-Yien ChienPo-Ren Hsueh
Mar 15, 2013·Journal of Korean Medical Science·Seo Yun KimDeog Kyeom Kim
Mar 21, 2019·The Cochrane Database of Systematic Reviews·Bhagteshwar SinghDerek J Sloan
May 19, 2010·Expert Review of Respiratory Medicine·Alberto MatteelliGiovanni Battista Migliori
Jul 24, 2013·The Clinical Respiratory Journal·Bárbara Flor de Lima, Margarida Tavares
Jul 9, 2010·Scandinavian Journal of Infectious Diseases·Chih-Cheng LaiPo-Ren Hsueh
Dec 17, 2008·International Journal of Antimicrobial Agents·Yu-Tsung Huang, Po-Ren Hsueh

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Antitubercular Agents (ASM)

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Antitubercular Agents

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

Emerging Infectious Diseases
Ming-Chih YuRuwen Jou
The Journal of Infection
Po-Ren HsuehKwen-Tay Luh
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Christie Y JeonLaura E Via
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
C C LaiP-R Hsueh
Emerging Infectious Diseases
Eduardo Hernández-Garduño, R Kevin Elwood
© 2022 Meta ULC. All rights reserved